Status:
COMPLETED
Influencing Factors of the Corneal Endothelial Cell Loss
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multi-center cohort study with prognostic aims to identify factors associated with endothelial cell loss during cataract surgery. Patients will have their endothelial density measured by sp...
Detailed Description
Cataract surgery is the most commonly performed surgical procedure worldwide. Postoperative visual function depends on implant into the crystalline lens, retinal lesion, corneal damage or glaucomatous...
Eligibility Criteria
Inclusion
- Patients undergoing cataract surgery
- Visual acuity monoyer scale \<8/10e (\> +0.2 logMar)
- Nuclear, cortical and posterior subcapsular cataract with normal density to severe in the LOCSIII classification
- Covered by the social security scheme
- Have given their oral agreement
Exclusion
- Corneal disease: keratitis, dystrophy or corneal degeneration
- Any disease of the anterior segment
- Low preoperative endothelial cell density \<1000 c/mm²
- Pregnancy, lactation
- Risk factors for surgical per-operative complication
- Uncontrolled ocular pressure
- Combined surgery (cataract with corneal graft, cataract with glaucoma surgery, cataract with vitrectomy, ....)
- Under legal protection
Key Trial Info
Start Date :
May 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 4 2023
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT05265832
Start Date
May 4 2022
End Date
September 4 2023
Last Update
December 26 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz-Thionville/Hopital Mercy
Metz, Grand Est, France, 57085
2
CHR Metz-Thionville_Hopital Bel Air
Thionville, Grand Est, France